PE20081368A1 - Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina - Google Patents

Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina

Info

Publication number
PE20081368A1
PE20081368A1 PE2007001202A PE2007001202A PE20081368A1 PE 20081368 A1 PE20081368 A1 PE 20081368A1 PE 2007001202 A PE2007001202 A PE 2007001202A PE 2007001202 A PE2007001202 A PE 2007001202A PE 20081368 A1 PE20081368 A1 PE 20081368A1
Authority
PE
Peru
Prior art keywords
azabicycle
group
heptane
recaptation
norepinephrine
Prior art date
Application number
PE2007001202A
Other languages
English (en)
Inventor
Barbara Bertani
Fabio Romano Di
Fabrizio Micheli
Giovanna Tedesco
Silvia Terreni
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0617868A external-priority patent/GB0617868D0/en
Priority claimed from GB0617863A external-priority patent/GB0617863D0/en
Priority claimed from GB0716371A external-priority patent/GB0716371D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20081368A1 publication Critical patent/PE20081368A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE AZABICICLO[4.1.0]HEPTANO DE FORMULA (A), EN DONDE R1 ES H O ALQUILO(C1-C4); R2 ES UN GRUPO A, K O W; DONDE A ES UN GRUPO DE FORMULA a); K ES UN GRUPO a O ß NAFTILO OPCIONALMENTE SUSTITUIDO POR R18; W ES DE FORMULA b), EN DONDE G ES HETEROARILO MONO O BICICLICO OPCIONALMENTE SUSTITUIDO CON (R15)p; R3 Y R4 SON INDEPENDIENTEMENTE H, F Y ALQUILO(C1-C4) O UN GRUPO X O X1; R5 Y R17 SON INDEPENDIENTEMENTE H O ALQUILO(C1-C4); R7 ES R5 O UN GRUPO X, X1, X2 O X3; DONDE X ES -(CH2)n-O-R16; X1 ES -(CH2)n-O-R19; X2 ES -CO-OR19; Y X3 ES -CO-NH2. SON SELECCIONADOS: (1S,6R/1R,6S)-6-(3,4-DICLOROFENIL)-1-[(METILOXI)METIL]-3-AZABICICLO[4.1.0]HEPTANO, [(1S,6R/1R,6S)-6-(3,4-DICLOROFENIL)-3-AZABICICLO[4.1.0]HEPT-1-IL]METANOL. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE LA RECAPTACION DE SEROTONINA (5-HT), DOPAMINA (DA) Y NOREPINEFRINA (NE), SIENDO UTILES EN EL TRATAMIENTO DE LA DEPRESION
PE2007001202A 2006-09-11 2007-09-07 Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina PE20081368A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0617868A GB0617868D0 (en) 2006-09-11 2006-09-11 Chemical compounds
GB0617863A GB0617863D0 (en) 2006-09-11 2006-09-11 Chemical compounds
GB0716371A GB0716371D0 (en) 2007-08-22 2007-08-22 Chemical compounds

Publications (1)

Publication Number Publication Date
PE20081368A1 true PE20081368A1 (es) 2008-11-19

Family

ID=38561834

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001202A PE20081368A1 (es) 2006-09-11 2007-09-07 Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina

Country Status (19)

Country Link
US (2) US7691893B2 (es)
EP (1) EP2064186A1 (es)
JP (1) JP4448198B2 (es)
KR (1) KR20090064447A (es)
AR (1) AR062737A1 (es)
AU (1) AU2007296301A1 (es)
BR (1) BRPI0716532A2 (es)
CA (1) CA2662538A1 (es)
CL (1) CL2007002619A1 (es)
CO (1) CO6150149A2 (es)
CR (1) CR10671A (es)
EA (1) EA200970266A1 (es)
IL (1) IL197297A0 (es)
MA (1) MA30767B1 (es)
MX (1) MX2009002625A (es)
NO (1) NO20091099L (es)
PE (1) PE20081368A1 (es)
TW (1) TW200826934A (es)
WO (1) WO2008031772A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0716532A2 (pt) 2006-09-11 2013-09-24 Glaxo Group Ltd compostos azabicÍclios como inidores de reabsorÇço de monoaminas
GB0716573D0 (en) * 2007-08-24 2007-10-03 Glaxo Group Ltd Chemical compounds
GB0804326D0 (en) * 2008-03-07 2008-04-16 Glaxo Group Ltd Novel compounds
WO2010125033A1 (en) * 2009-04-29 2010-11-04 Glaxo Group Limited Azabicyclo[4.1.0]heptane derivatives
WO2010130672A1 (en) * 2009-05-12 2010-11-18 Glaxo Group Limited Azabicyclo [4.1.0] heptane derivatives and their use as monoamine reuptake inhibitors
WO2010133569A1 (en) * 2009-05-20 2010-11-25 Glaxo Group Limited Azabicyclo[4.1.0]heptane derivatives
WO2010146025A1 (en) * 2009-06-17 2010-12-23 Glaxo Group Limited Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
SI2626350T1 (sl) 2010-09-22 2015-09-30 Eisai R&D Management Co., Ltd. Spojina ciklopropana
DE102011100831A1 (de) 2011-05-07 2012-11-08 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von GSK 1360707 und verwandter Verbindungen mit 6-Aryl-1-[(alkyloxy) alkyl]-3-azabicyclo[4.1.0]heptan Grundgerüst
WO2016063995A1 (en) 2014-10-23 2016-04-28 Eisai R&D Management Co., Ltd. Compositions and methods for treating insomnia

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2008A (en) * 1841-03-18 Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
US2004A (en) * 1841-03-12 Improvement in the manner of constructing and propelling steam-vessels
US4131611A (en) 1975-07-31 1978-12-26 American Cyanamid Company Azabicyclohexanes
US4435419A (en) 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
ES2159839T3 (es) 1996-02-22 2001-10-16 Neurosearch As Derivados del propano, su preparacion y su uso.
ES2329739T3 (es) * 1997-04-07 2009-11-30 Georgetown University Analogos de cocaina.
US6303627B1 (en) * 1998-06-19 2001-10-16 Eli Lilly And Company Inhibitors of serotonin reuptake
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US6569887B2 (en) 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
DE10306250A1 (de) 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
EP1735302B1 (en) * 2004-02-27 2010-06-16 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
BRPI0716532A2 (pt) 2006-09-11 2013-09-24 Glaxo Group Ltd compostos azabicÍclios como inidores de reabsorÇço de monoaminas

Also Published As

Publication number Publication date
EP2064186A1 (en) 2009-06-03
WO2008031772A1 (en) 2008-03-20
US20080114049A1 (en) 2008-05-15
CA2662538A1 (en) 2008-03-20
CL2007002619A1 (es) 2008-04-18
US7691893B2 (en) 2010-04-06
IL197297A0 (en) 2009-12-24
CO6150149A2 (es) 2010-04-20
JP2010502761A (ja) 2010-01-28
AR062737A1 (es) 2008-11-26
MA30767B1 (fr) 2009-10-01
NO20091099L (no) 2009-04-03
CR10671A (es) 2009-04-29
JP4448198B2 (ja) 2010-04-07
MX2009002625A (es) 2009-03-24
AU2007296301A1 (en) 2008-03-20
EA200970266A1 (ru) 2009-08-28
US20100035914A1 (en) 2010-02-11
BRPI0716532A2 (pt) 2013-09-24
KR20090064447A (ko) 2009-06-18
TW200826934A (en) 2008-07-01

Similar Documents

Publication Publication Date Title
PE20081368A1 (es) Derivados de azabiciclo[4.1.0]heptano como inhibidores de la recaptacion de serotonina, dopamina y norepinefrina
PH12017501192B1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
PE20091376A1 (es) Derivados de fenilamino como moduladores de beta-amiloide
PE20130375A1 (es) Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
MY163498A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
EA201000484A1 (ru) Тиенопиримидиновые и пиразолопиримидиновые соединения и их применение в качестве ингибиторов киназы mtor и киназы pi3
DOP2005000071A (es) "compuestos de metil-aril o heteroaril-amida sustituida"
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
TW200639158A (en) New compounds with therapeutic effect
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA200970856A1 (ru) Ингибиторы пути хеджхога
DE602006006850D1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
BRPI0809656B8 (pt) atropisômero, composto, agente profilático ou terapêutico, e, composição farmacêutica
PE20070491A1 (es) Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina
UA99447C2 (ru) Способ получения силденафила
ATE484502T1 (de) Neue verbindungen
EA200970793A1 (ru) Модуляторы рецепторов, активируемых пролифераторами пероксисом
EA201200602A1 (ru) Индазолы и пиразолопиридины в качестве антагонистов рецептора ccr1
EA201490722A1 (ru) ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНОГО РЕЦЕПТОРА ГЛУТАМАТА mGluR5
PE20081831A1 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
AR074801A1 (es) Monocarbamas y composiciones farmaceuticas que los contienen
MX2009011922A (es) Tetrahidrobenzazepinas ariloxi- y heteroariloxi-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
EA201100350A1 (ru) Противогрибковые средства
DE602005014629D1 (de) Pyrazolphenylderivate als ppar-aktivatoren
BRPI0513083A (pt) oxazolidinonas contendo oxindóis como agentes antibacterianos

Legal Events

Date Code Title Description
FC Refusal